21 CFR 111.70(b)(2) citations

Specifications-component purity, strength, composition

FDA investigators cited 21 CFR 111.70(b)(2) 513 times at 397 facilities in the inspection citations FDA publishes, most recently in an inspection that ended Jul 25, 2024. A citation is an observation listed on Form FDA 483 at the end of an inspection; it is not a final agency decision.

Citations by fiscal year

FDA fiscal yearCitations
202458
202346
202244
202128
202028
201937
201837
201743
201634
201525

Recent citations

The latest inspections that cited this section. Facility names link to each facility's FDA record.

Inspection endedFacilityCountryObservation
Jul 25, 2024Hyalogic LLCUnited StatesYou did not establish component specifications for purity and strength.
Jul 19, 2024PRC, IncUnited StatesYou did not establish component specifications for purity, strength and composition.
Jul 17, 2024Alfa Vitamins Laboratories Inc.United StatesYou did not establish component specifications for strength and composition.
Jul 17, 2024Dert Inc.United StatesYou did not establish component specifications for purity, strength and composition.
Jul 12, 2024Country Life, LLCUnited StatesYou did not establish component specifications for purity, strength and composition.
Jul 11, 2024Greenland IncUnited StatesYou did not establish component specifications for purity, strength and composition.
Jul 10, 2024Al Global, Inc.United StatesYou did not establish component specifications for purity, strength and composition.
Jun 25, 2024Aqua Nutraceuticals LLCUnited StatesYou did not establish component specifications for purity, strength and composition.
Jun 14, 2024Pinnacle Labs International, Inc.United StatesYou did not establish component specifications for purity, strength and composition.
Jun 14, 2024US FOOD MANUFACTURINGUnited StatesYou did not establish component specifications for purity, strength and composition.
Jun 13, 2024Penn Herb Company, Ltd.United StatesYou did not establish component specifications for purity, strength and composition.
Jun 7, 2024Mcclarry Innovation LLCUnited StatesYou did not establish component specifications for purity, strength and composition.
May 31, 2024TCI (TAIWAN) S5 PABP BRANCHTaiwanYou did not establish component specifications for purity, strength and composition.
May 28, 2024I AM WELL HOLISTIC INCUnited StatesYou did not establish component specifications for purity, strength and composition.
May 28, 2024REVE PHARMAIndiaYou did not establish component specifications for strength.
May 24, 2024General Research LaboratoriesUnited StatesYou did not establish component specifications for purity, strength and composition.
May 24, 2024Himalaya Wellness CompanyIndiaYou did not establish component specifications for strength.
May 22, 2024Florida Nutrition Inc.United StatesYou did not establish component specifications for purity, strength and composition.
May 17, 2024FCC Horiuchi Co., Ltd.JapanYou did not establish component specifications for purity, strength and composition.
May 16, 2024Dr Ma's Laboratories, Inc.CanadaYou did not establish component specifications for purity, strength and composition.
May 13, 2024North American Herb And Spice Co. LTD, LLCUnited StatesYou did not establish component specifications for purity.
May 10, 2024Pro Line Nutrition LTD.CanadaYou did not establish component specifications for purity, strength and composition.
Apr 26, 2024BodyBio Inc.United StatesYou did not establish component specifications for purity and strength.
Apr 22, 2024BF Suma Pharmaceuticals, Inc.United StatesYou did not establish component specifications for purity, strength and composition.
Apr 22, 2024Enrinity Supplements, Inc.United StatesYou did not establish component specifications for purity, strength and composition.

Search more

Search every Form 483 citation by company with the FDA 483 search, see all frequently cited CFR sections, or check one supplier with the free FDA compliance check.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.